CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer

CIMAvax-EGF: A novel therapeutic vaccine for advanced lung cancer

The results allowing the Cuban Regulatory Agency (CECMED) to grant the Sanitary Registration to the CIMAvax-EGF cancer vaccine for advanced non-small cell lung cancer (NSCLC) are shown. This was the first registration of a therapeutic vaccine in Cuba and also the first registration of a lung cancer...

Full description

Bibliographic Details
Main Authors: Gisela González, Agustin Lage, Tania Crombet, Gryssel Rodríguez, Beatriz García, Ariadna Cuevas, Lisel Viña, Norkis Arteaga, Elia Neninger
Format: Article
Language:English
Published: Elfos Scientiae
Series:Biotecnología Aplicada
Subjects:
cancer vaccine
nsclc
fast-track registration
cimavax-egf
phase ii-iii clinical trial
Online Access:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522009000400009&lng=en&tlng=en

Internet

http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522009000400009&lng=en&tlng=en

Similar Items